Investigation of the expression level of methylated septin 9 gene and serological carcinoembryonic antigen to diagnose colorectal cancer. A meta-analysis study
Sharifeh Jorboniyan, Haniyeh Bashi Zadeh Fakhar, Mohammad-Esmaiel Akbari, Neda Izadi, Shaghayegh Rangraz · 2024
Read Investigation of the expression level of methylated septin 9 gene and serological carcinoembryonic antigen to diagnose colorectal cancer. A meta-analysis study by Sharifeh Jorboniyan, Haniyeh Bashi Zadeh Fakhar, Mohammad-Esmaiel Akbari, Neda Izadi, Shaghayegh Rangraz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11726225.txt.
Description
Sharifeh Jorboniyan and four co-authors run a meta-analysis, in 2024, of two blood markers for colorectal cancer diagnosis. One marker is methylated septin 9, and the other is carcinoembryonic antigen, a long-used test. Studies in English from January 2012 to December 2022 were gathered from PubMed and Google Scholar.
Methylated septin 9 showed 71 percent sensitivity and 91 percent specificity, well above the antigen test on both counts. An eight-study analysis also linked higher levels of both markers to higher tumour grade, most clearly at stages 3 and 4. The authors urge adding septin 9 to diagnostic frameworks to improve early detection and care.
Catalog record
| CREATOR | Sharifeh Jorboniyan, Haniyeh Bashi Zadeh Fakhar, Mohammad-Esmaiel Akbari, Neda Izadi, Shaghayegh Rangraz |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |